lansoprazole has been researched along with Ophthalmoplegia, Progressive Supranuclear in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fawaz, MV | 1 |
| Brooks, AF | 1 |
| Rodnick, ME | 1 |
| Carpenter, GM | 1 |
| Shao, X | 1 |
| Desmond, TJ | 1 |
| Sherman, P | 1 |
| Quesada, CA | 1 |
| Hockley, BG | 1 |
| Kilbourn, MR | 1 |
| Albin, RL | 1 |
| Frey, KA | 1 |
| Scott, PJ | 1 |
1 other study available for lansoprazole and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoradiography; Brain; Carbon Radioisotopes; Dru | 2014 |